Adherence and sustained virologic response among vulnerable people initiating an hepatitis C treatment at a nurse-led clinic: A non-experimental prospective cohort study based on clinical records

Aldridge, 2018, Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis, Lancet, 391, 241, 10.1016/S0140-6736(17)31869-X Zeuzem, 2018, Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection, N. Engl. J. Med., 378, 354, 10.1056/NEJMoa1702417 Axley, 2018, Hepatitis C virus and hepatocellular carcinoma: a narrative review, J. Clin. Transl. Hepatol., 6, 79 Backus, 2018, Direct-acting antiviral sustained virologic response: impact on mortality in patients without advanced liver disease, Hepatology, 68, 827, 10.1002/hep.29811 Benchimol, 2015, The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement, PLoS Med., 12, 10.1371/journal.pmed.1001885 Chen, 2006, The natural history of hepatitis C virus (HCV) infection, Int. J. Med. Sci., 3, 47, 10.7150/ijms.3.47 de Ledinghen, 2006, Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients, J. Acquir. Immune Defic. Syndr., 41, 175, 10.1097/01.qai.0000194238.15831.c7 de Oliveria Andrade, 2009, Association between hepatitis C and hepatocellular carcinoma, J. Glob. Infect. Dis, 1, 33, 10.4103/0974-777X.52979 Feld, 2015, Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection, N. Engl. J. Med., 373, 2599, 10.1056/NEJMoa1512610 Gentil, 2019, Profiles of quality of life in a homeless population, Front. Psychiatry, 10, 10, 10.3389/fpsyt.2019.00010 Gentil, 2020, Satisfaction with health and community services among homeless and formerly homeless individuals in Quebec, Canada, Health Soc. Care Community, 28, 22, 10.1111/hsc.12834 Hajarizadeh, 2018, Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis, Lancet Gastroenterol. Hepatol., 3, 754, 10.1016/S2468-1253(18)30304-2 Jacobson, 2012, Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations, J. Viral Hepat., 19, 236, 10.1111/j.1365-2893.2011.01552.x Larney, 2017, Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review, Lancet Glob. Health., 5, 10.1016/S2214-109X(17)30373-X Lewer, 2019, Health-related quality of life and prevalence of six chronic diseases in homeless and housed people: a cross-sectional study in London and Birmingham, England, BMJ Open, 9, 10.1136/bmjopen-2018-025192 Lewis, 2016, Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment, Eur. J. Gastroenterol. Hepatol., 28, 1258, 10.1097/MEG.0000000000000711 Lloyd, 2013, Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting, Clin. Infect. Dis., 56, 1078, 10.1093/cid/cis1202 Luchenski, 2018, What works in inclusion health: overview of effective interventions for marginalised and excluded populations, Lancet, 391, 266, 10.1016/S0140-6736(17)31959-1 McHutchison, 2009, Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection, N. Engl. J. Med., 361, 580, 10.1056/NEJMoa0808010 Miller, 2014, British viral hepatitis group, British society of gastroenterology liver committee, British association for the study of liver, Scottish society of gastroenterology, Scottish viral hepatitis group, Scottish viral hepatitis nurses group, Aliment Pharmacol. Ther., 39, 1363, 10.1111/apt.12764 Nitulescu, 2019, Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals, Int. J. Drug Policy, 65, 41, 10.1016/j.drugpo.2018.08.012 Overton, 2019, Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting, Int. J. Drug Policy, 72, 123, 10.1016/j.drugpo.2019.02.013 Papaluca, 2019, Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care, J. Hepatol., 70, 839, 10.1016/j.jhep.2019.01.012 Perrett, 2011, Prisoner health: assessing a nurse-led hepatitis C testing clinic, Br. J. Nurs., 20, 611, 10.12968/bjon.2011.20.10.611 Popping, 2019, The global campaign to eliminate HBV and HCV infection: international Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals, J. Virus Erad., 5, 60, 10.1016/S2055-6640(20)30281-8 Richmond, 2020, Achieving hepatitis C elimination by using person-centered, nurse-led models of care: a discussion of four international case studies, Gastroenterol. Nurs., 43, 303, 10.1097/SGA.0000000000000458 Saeed, 2020, Eliminating structural barriers: the impact of unrestricted access on hepatitis C treatment uptake among people living with HIV, Clin. Infect. Dis., 71, 363, 10.1093/cid/ciz833 Shah, 2018, The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver, CMAJ, 190, 10.1503/cmaj.170453 Smith-Palmer, 2015, Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits, BMC Infect. Dis., 15, 19, 10.1186/s12879-015-0748-8 Socias, 2019, Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting, Liver Int., 39, 1400, 10.1111/liv.14043 Stanaway, 2016, The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013, Lancet, 388, 1081, 10.1016/S0140-6736(16)30579-7 Suwanthawornkul, 2015, Efficacy of second generation direct-acting antiviral agents for treatment naive hepatitis C genotype 1: a systematic review and network meta-analysis, Plos One, 10, e0145953, 10.1371/journal.pone.0145953 Tait, 2010, The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre, J Viral Hepat., 17, 698, 10.1111/j.1365-2893.2009.01227.x 2017, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, Lancet Gastroenterol. Hepatol., 2, 161, 10.1016/S2468-1253(16)30181-9 Vandenbroucke, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration, PLoS Med., 4, e297, 10.1371/journal.pmed.0040297 Vo, 2015, Poor sustained virological response in a multicenter real-life cohort of chronic hepatitis C patients treated with pegylated interferon and ribavirin plus telaprevir or boceprevir, Dig. Dis. Sci., 60, 1045, 10.1007/s10620-015-3621-0 Wolstenholme, 2020, Innovating access to the nurse-led hepatitis C clinic using co-production, J. Res. Nurs., 25, 211, 10.1177/1744987120914353 2016 American Association for the Study of Liver Diseases, Infectious Diseases Society of America, 2019. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Available at: www.hcvguidelines.org.